We are live on ! Find out more
AC

AXQ Capital Portfolio holdings

AUM $777M
1-Year Est. Return 9.87%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+9.87%
3 Year Est. Return
+23.94%
5 Year Est. Return
10 Year Est. Return
AUM
$310M
AUM Growth
+$60.3M
Cap. Flow
+$49M
Cap. Flow %
15.81%
Top 10 Hldgs %
7.4%
Holding
817
New
340
Increased
127
Reduced
80
Closed
270

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$2.34M
2
PCG icon
PG&E
PCG
+$2.05M
3
GDDY icon
GoDaddy
GDDY
+$2.02M
4
STZ icon
Constellation Brands
STZ
+$1.93M
5
RHI icon
Robert Half
RHI
+$1.84M

Top Sells

Rank Stock Value
1
NEE icon
NextEra Energy
NEE
+$2.51M
2
CRM icon
Salesforce
CRM
+$2.17M
3
CSX icon
CSX Corp
CSX
+$1.98M
4
DLTR icon
Dollar Tree
DLTR
+$1.79M
5
MLM icon
Martin Marietta Materials
MLM
+$1.74M

Sector Composition

Rank Sector Weight
1 Technology 19.82%
2 Industrials 15.73%
3 Financials 15.52%
4 Consumer Discretionary 13.8%
5 Healthcare 11.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UDMY
526
DELISTED
Udemy
UDMY
$75K 0.02%
+10,673
New +$73.6K
CLNE icon
527
Clean Energy Fuels
CLNE
$416M
$74.6K 0.02%
+38,232
New +$65K
EVEX icon
528
Eve Holding
EVEX
$777M
$73.5K 0.02%
+10,721
New +$47.8K
STEM icon
529
Stem
STEM
$44.3M
$71.9K 0.02%
+11,541
New +$103K
CATX icon
530
Perspective Therapeutics
CATX
$327M
$70.5K 0.02%
+20,480
New +$54.1K
OSUR icon
531
OraSure Technologies
OSUR
$273M
$69.6K 0.02%
+23,199
New +$66.9K
KRNY icon
532
Kearny Financial
KRNY
$604M
$68.7K 0.02%
+10,637
New +$65.6K
GRNT icon
533
Granite Ridge Resources
GRNT
$621M
$64.9K 0.02%
+10,187
New +$56.1K
RYAM icon
534
Rayonier Advanced Materials
RYAM
$562M
$63K 0.02%
+16,359
New +$68.7K
FUBO icon
535
FuboTV Inc
FUBO
$260M
$59.5K 0.02%
+1,284
New +$48K
VYGR icon
536
Voyager Therapeutics
VYGR
$181M
$57.6K 0.02%
+18,516
New +$59.7K
LRMR icon
537
Larimar Therapeutics
LRMR
$377M
$57.4K 0.02%
+19,853
New +$46K
ABUS icon
538
Arbutus Biopharma
ABUS
$847M
$57.3K 0.02%
+18,545
New +$61.6K
IBRX icon
539
ImmunityBio
IBRX
$7.15B
$51.8K 0.02%
19,622
+4,948
+34% +$13.3K
SSP icon
540
E.W. Scripps
SSP
$270M
$51.5K 0.02%
17,502
+6,012
+52% +$14.5K
TDAY
541
USA Today Co
TDAY
$1.29B
$51.4K 0.02%
14,358
-9,805
-41% -$32.9K
LXEO icon
542
Lexeo Therapeutics
LXEO
$338M
$50.1K 0.02%
+12,475
New +$41K
CNDT icon
543
Conduent
CNDT
$253M
$46.4K 0.02%
17,588
-5,747
-25% -$13.5K
RILY icon
544
BRC Group Holdings
RILY
$264M
$42.9K 0.01%
+14,446
New +$44.4K
TLS icon
545
Telos
TLS
$331M
$38.6K 0.01%
+12,169
New +$31.6K
KYTX icon
546
Kyverna Therapeutics
KYTX
$430M
$31.9K 0.01%
+10,375
New +$25.7K
TEAD
547
Teads Holding Co
TEAD
$76.2M
$26K 0.01%
10,497
-3,604
-26% -$10.9K
A icon
548
Agilent Technologies
A
$39.6B
-8,526
Closed -$997K
ABT icon
549
Abbott
ABT
$187B
-5,316
Closed -$705K
ACCO icon
550
Acco Brands
ACCO
$399M
-19,569
Closed -$82K

Similar funds

AXQ Capital's Q2 2025 Portfolio in Review

As of Q2 2025, AXQ Capital held 817 positions worth $310M, up 24% from $249M the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

AXQ Capital deployed $49M of net new capital in Q2 2025, opening 340 new positions and adding to 127 existing holdings. Its largest new stake was Thermo Fisher Scientific: 5,591 shares worth $2.27M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was MGIC Investment, an estimated $1.65M trimmed.

  • AXQ Capital's largest Q2 2025 buy was Thermo Fisher Scientific: 5,591 shares worth $2.27M.
  • AXQ Capital added most to PG&E in Q2 2025, an estimated $2.05M increase.
  • AXQ Capital's biggest Q2 2025 reduction was MGIC Investment, cutting an estimated $1.65M.
  • AXQ Capital fully exited NextEra Energy in Q2 2025, selling an estimated $2.51M.
  • AXQ Capital's ten largest holdings make up 7.4% of its $310M portfolio in Q2 2025.
  • AXQ Capital opened 340 new positions and closed 270 in Q2 2025.
  • AXQ Capital's portfolio value rose 24% quarter-over-quarter to $310M.

Based on AXQ Capital's 13F filing for Q2 2025, filed 12 Aug 2025.